Delivery Order SPE2DB22D3301-SPE2DB25FY7WE
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 10 milliliter vials of insulin aspart 100 unit/milliliter. The contract has a firm fixed price of $2,276.20 and an ultimate completion date of May 23, 2025. The award is not set-aside and was issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL vials, a diabetes medication. The contract has a firm fixed price of $2,342.45 and an ultimate completion date of May 30, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a $1,499.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial 10mL. The contract has an ultimate completion date of April 2, 2025 and is not associated with a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,743,151 units of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $4,266.02. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Insulin Aspart 100 Unit/mL in 10 mL vials. The contract has a ceiling value of $1,097.40 and an ultimate completion date of May 30, 2025. This order is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The $6,125.48 firm fixed-price contract has an ultimate completion date of August 24, 2023. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL Vial 10mL, a critical diabetes medication. The total ceiling value of the contract is $1,809.60, with a period of performance through January 30, 2025. The contract was awarded on a firm-fixed price basis without any set-aside designation, indicating open...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 milliliter vials of Insulin Aspart 100 Unit/mL, a medication used to treat diabetes. The contract has a ceiling value of $3,127.45 and a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.21, is for the delivery of insulin aspart 100 unit/mL pen 3mL. The contract has a completion date of June 27, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN ASPART 100 UNIT/ML VL 10ML, a diabetes treatment medication. The award has a firm fixed price of $1,734.04 and a completion date of June 12, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...